{"The": [0], "SARS-CoV-2": [1], "B.1.1.529": [2], "(Omicron)": [3], "variant": [4], "contains": [5], "15": [6], "mutations": [7, 36, 71, 156, 165], "of": [8, 33, 72, 78, 90, 134, 173, 190, 247], "the": [9, 31, 46, 88, 94, 174, 187, 234, 245], "receptor-binding": [10], "domain": [11], "(RBD).": [12], "How": [13], "Omicron": [14, 73, 146, 221, 253], "evades": [15], "RBD-targeted": [16], "neutralizing": [17, 41, 47, 76, 83, 124, 135, 151, 176, 231], "antibodies": [18, 42, 48, 77, 84, 136, 152, 177, 232], "requires": [19], "immediate": [20], "investigation.": [21], "Here": [22], "we": [23], "use": [24], "high-throughput": [25], "yeast": [26], "display": [27], "screening1,2": [28], "to": [29, 162, 184], "determine": [30], "profiles": [32], "RBD": [34], "escaping": [35], "for": [37], "247": [38], "human": [39], "anti-RBD": [40], "and": [43, 104, 113, 143, 197, 206, 229, 250, 254], "show": [44], "that": [45, 61, 150, 153, 218, 230], "can": [49, 74], "be": [50, 159], "classified": [51], "by": [52, 100, 129, 140, 180, 202], "unsupervised": [53], "clustering": [54], "into": [55], "six": [56], "epitope": [57, 80], "groups": [58, 86], "(A-F)-a": [59], "grouping": [60], "is": [62], "highly": [63], "concordant": [64], "with": [65, 93, 220], "knowledge-based": [66], "structural": [67], "classifications3-5.": [68], "Various": [69], "single": [70, 155], "impair": [75], "different": [79], "groups.": [81], "Specifically,": [82], "in": [85, 107, 224], "A-D,": [87], "epitopes": [89], "which": [91, 119], "overlap": [92], "ACE2-binding": [95], "motif,": [96], "are": [97, 126, 137], "largely": [98], "escaped": [99, 139, 179], "K417N,": [101], "G446S,": [102], "E484A": [103], "Q493R.": [105], "Antibodies": [106], "group": [108, 114], "E": [109], "(for": [110, 116], "example,": [111, 117], "S309)6": [112], "F": [115], "CR3022)7,": [118], "often": [120], "exhibit": [121], "broad": [122], "sarbecovirus": [123, 235], "activity,": [125], "less": [127], "affected": [128], "Omicron,": [130, 203], "but": [131], "a": [132, 211], "subset": [133], "still": [138, 208], "G339D,": [141], "N440K": [142], "S371L.": [144], "Furthermore,": [145], "pseudovirus": [147], "neutralization": [148, 188], "showed": [149], "sustained": [154], "could": [157], "also": [158], "escaped,": [160], "owing": [161], "multiple": [163], "synergetic": [164], "on": [166], "their": [167], "epitopes.": [168], "In": [169], "total,": [170], "over": [171], "85%": [172], "tested": [175], "were": [178], "Omicron.": [181], "With": [182], "regard": [183], "neutralizing-antibody-based": [185], "drugs,": [186], "potency": [189], "LY-CoV016,": [191], "LY-CoV555,": [192], "REGN10933,": [193], "REGN10987,": [194], "AZD1061,": [195], "AZD8895": [196], "BRII-196": [198], "was": [199], "greatly": [200], "undermined": [201], "whereas": [204], "VIR-7831": [205], "DXP-604": [207], "functioned": [209], "at": [210], "reduced": [212], "efficacy.": [213], "Together,": [214], "our": [215], "data": [216], "suggest": [217], "infection": [219], "would": [222], "result": [223], "considerable": [225], "humoral": [226], "immune": [227], "evasion,": [228], "targeting": [233], "conserved": [236], "region": [237], "will": [238], "remain": [239], "most": [240], "effective.": [241], "Our": [242], "results": [243], "inform": [244], "development": [246], "antibody-based": [248], "drugs": [249], "vaccines": [251], "against": [252], "future": [255], "variants.": [256]}